What is N-Acetyl Epitalon Amidate?

Epitalon (Ala-Glu-Asp-Gly) with an acetyl cap and amide end, sold as a more stable variant; human data exist only for plain Epitalon.

N-Acetyl Epitalon Amidate in the library · Bioregulator Peptides · Human Trials · What are peptides?

0 registered trials · 0 indexed papers · 16 human / 89 animal studies

From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.

What it is

N-Acetyl Epitalon Amidate is described as a modified version of the tetrapeptide Epitalon, which has its own page. The changes aim to slow enzyme breakdown.

Mechanism (as described)

  • The proposed mechanism is the same as Epitalon (telomerase and pineal-related research); no published work tests the modified form.

Evidence (as described)

  • No study of the acetylated amidated form is on file. A 2025 review summarizes Epitalon research overall (Araj et al., 2025).

Status

Not approved.

More cited research

Related compounds

FAQ

What is N-Acetyl Epitalon Amidate?

Epitalon (Ala-Glu-Asp-Gly) with an acetyl cap and amide end, sold as a more stable variant; human data exist only for plain Epitalon.

How many registered human trials study N-Acetyl Epitalon Amidate?

The PeptideWhiz trial index lists 0 registered trials for N-Acetyl Epitalon Amidate.

How much published research exists on N-Acetyl Epitalon Amidate?

By study type, PeptideWhiz counts 16 human and 89 animal studies on N-Acetyl Epitalon Amidate.

Which conditions is N-Acetyl Epitalon Amidate researched for?

No condition pages are linked to this compound yet.

Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).